Published in Ann Surg Oncol on February 28, 2014
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. J Natl Cancer Inst (2015) 1.72
Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Ann Surg Oncol (2015) 0.78
Trends and controversies in multidisciplinary care of the patient with breast cancer. Curr Probl Surg (2016) 0.75
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys (2014) 3.69
Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg (2005) 2.00
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov (2011) 7.65
Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol (2004) 4.03
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg (2012) 2.37
CYP2D6 testing in breast cancer: ready for prime time? Oncology (Williston Park) (2009) 2.11
The role of radiation therapy in resected T2 N0 esophageal cancer: a population-based analysis. Ann Thorac Surg (2012) 2.08
Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg (2012) 2.08
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol (2005) 2.06
Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer? Ann Thorac Surg (2013) 1.98
Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A (2011) 1.97
Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res (2003) 1.71
Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg (2010) 1.70
Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer. J Thorac Oncol (2013) 1.53
Resident education in the era of patient safety: a nationwide analysis of outcomes and complications in resident-assisted oncologic surgery. Ann Surg Oncol (2013) 1.52
Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation. Am J Respir Crit Care Med (2013) 1.49
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat (2010) 1.42
Correlation between financial relationships with commercial interests and research prominence at an oncology meeting. J Clin Oncol (2013) 1.40
Current Trends in the Management of Ductal Carcinoma In Situ. Oncology (Williston Park) (2016) 1.39
Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg (2009) 1.39
Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol (2006) 1.34
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin Cancer Res (2009) 1.23
Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat (2011) 1.17
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer (2008) 1.13
Self-reported financial burden and satisfaction with care among patients with cancer. Oncologist (2014) 1.13
Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer. Ann Thorac Surg (2012) 1.07
Exercise research: early promise warrants further investment. Lancet Oncol (2010) 1.07
Language barriers and patient-centered breast cancer care. Patient Educ Couns (2010) 1.07
Quantifying the recruitment challenges with couple-based interventions for cancer: applications to early-stage breast cancer. Psychooncology (2009) 1.06
Identification of a robust gene signature that predicts breast cancer outcome in independent data sets. BMC Cancer (2007) 1.02
Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors. Mod Pathol (2005) 1.00
The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer (2011) 1.00
Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer (2010) 1.00
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) (2013) 0.99
Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer. Cancer Invest (2009) 0.99
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer (2009) 0.99
Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg (2005) 0.98
Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt) (2010) 0.97
Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg (2012) 0.97
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes. Breast Cancer Res (2012) 0.97
Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol (2012) 0.97
Status of Intraductal Therapy for Ductal Carcinoma in Situ. Curr Breast Cancer Rep (2010) 0.96
Early palliative care in cancer treatment: rationale, evidence and clinical implications. Ther Adv Med Oncol (2013) 0.96
Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer (2012) 0.95
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res Treat (2012) 0.95
Adjuvant hormonal therapy use among women with ductal carcinoma in situ. J Womens Health (Larchmt) (2011) 0.94
Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol (2014) 0.93
Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys (2010) 0.92
Long-term reconstructive outcomes after expander-implant breast reconstruction with serious infectious or wound-healing complications. Ann Plast Surg (2012) 0.92
Addressing the American health-care cost crisis: role of the oncology community. J Natl Cancer Inst (2013) 0.91
Pre-exercise screening and prescription guidelines for cancer patients. Lancet Oncol (2010) 0.91
Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies. J Clin Oncol (2012) 0.90
Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer. Breast Cancer Res Treat (2011) 0.89
Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer. Int J Radiat Oncol Biol Phys (2012) 0.89
The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study. Breast Cancer Res Treat (2013) 0.88
Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA Intern Med (2013) 0.88
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast. Breast Cancer Res Treat (2013) 0.87
Total skin-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol (2013) 0.87
Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ. Breast J (2012) 0.86
Survivorship: healthy lifestyles, version 2.2014. J Natl Compr Canc Netw (2014) 0.86
Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum Pathol (2004) 0.86
Ethical challenges: oncologists' role in immigrant health care. J Oncol Pract (2010) 0.86
Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg (2014) 0.86
Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017. Ann Surg Oncol (2014) 0.86
Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis. Ann Surg (2015) 0.85
Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer. Semin Oncol (2013) 0.85
Availability of experimental therapy outside oncology randomized clinical trials in the United States. J Clin Oncol (2010) 0.85
Bacteriologic features of surgical site infections following breast surgery. Am J Surg (2009) 0.85
Incidence and management of biliary pancreatitis in cholecystectomized patients. Results of a 7-year study. J Gastrointest Surg (2003) 0.84
The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS. Breast Cancer Res Treat (2011) 0.84
Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women. J Cancer Surviv (2013) 0.83
Issues surrounding biospecimen collection and use in clinical trials. J Oncol Pract (2010) 0.83
The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases. Obes Surg (2013) 0.82
Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J (2003) 0.82
A 10-year longitudinal analysis of surgical management for acute ischemic colitis. J Gastrointest Surg (2012) 0.82
Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg (2012) 0.82
Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat (2005) 0.82
Pancreatic sepsis: prevention and therapy. Best Pract Res Clin Gastroenterol (2002) 0.82
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast (2011) 0.81
Breast cancer in young women: a new color or a different shade of pink? J Clin Oncol (2008) 0.81
Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J (2005) 0.81
Beyond toxicity: the challenge and importance of understanding the full impact of treatment decisions. Cancer (2009) 0.81
Applying the neoadjuvant paradigm to ductal carcinoma in situ. Ann Surg Oncol (2004) 0.80
Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J (2014) 0.80
Reporting of race and ethnicity in breast cancer research: room for improvement. Breast Cancer Res Treat (2009) 0.80
Ethical considerations for the clinical oncologist in an era of oncology drug shortages. Oncologist (2014) 0.79
Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. J Thorac Oncol (2013) 0.79
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patients. Ann Surg Oncol (2013) 0.79
Features of occult invasion in biopsy-proven DCIS at breast MRI. Breast J (2013) 0.79
Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg (2013) 0.79
Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2014) 0.78
Cefepime tissue penetration in experimental acute pancreatitis. Pancreas (2003) 0.78
Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy Is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone. Dis Colon Rectum (2016) 0.78
Comparison of body composition assessment methods in breast cancer survivors. Oncol Nurs Forum (2011) 0.78
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol (2013) 0.78
Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg (2004) 0.78
Erratum to: Exercise therapy in the management of solid tumors. Curr Treat Options Oncol (2010) 0.77
Multidisciplinary care of patients with early-stage breast cancer. Surg Oncol Clin N Am (2013) 0.77